Dabigatran – bloody hell revisited


So the trick is, bring out a dangerous medication with marginal benefit (in the shape of convenience) and increased side effect profile, then shortly after, release the assay to monitor the effect, and da-dah, no more problem, eh? Big pharma to the rescue!

My original post on this topic is trackbacked here.


About dreapadoir

Emergency Physician, author of http://underneathEM.com Emergency Medicine blog, photographer at http://www.dreapadoir.com
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s